应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MIST Milestone Pharmaceuticals Inc.
休市中 07-11 16:00:00 EDT
1.56
-1.00
-39.06%
盘后
1.61
+0.05
+3.16%
19:59 EDT
最高
1.94
最低
1.46
成交量
2,124万
今开
1.74
昨收
2.56
日振幅
18.75%
总市值
8,340万
流通市值
7,948万
总股本
5,346万
成交额
3,408万
换手率
41.69%
流通股本
5,095万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.00%
市场透视 · 07-10 19:28
Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.00%
Milestone Pharmaceuticals Inc.盘中异动 早盘急速拉升5.15%
市场透视 · 07-07
Milestone Pharmaceuticals Inc.盘中异动 早盘急速拉升5.15%
Milestone Pharmaceuticals Inc.盘中异动 快速上涨5.01%报1.88美元
市场透视 · 06-25
Milestone Pharmaceuticals Inc.盘中异动 快速上涨5.01%报1.88美元
Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨5.33%报1.78美元
市场透视 · 06-23
Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨5.33%报1.78美元
Milestone Pharmaceuticals Inc.盘中异动 早盘股价大涨5.15%
市场透视 · 06-05
Milestone Pharmaceuticals Inc.盘中异动 早盘股价大涨5.15%
Milestone Pharmaceuticals Inc.盘中异动 早盘急速拉升6.17%报1.72美元
市场透视 · 06-02
Milestone Pharmaceuticals Inc.盘中异动 早盘急速拉升6.17%报1.72美元
Milestone Pharmaceuticals Inc.盘中异动 急速下挫5.03%报1.51美元
市场透视 · 05-30
Milestone Pharmaceuticals Inc.盘中异动 急速下挫5.03%报1.51美元
Milestone Pharmaceuticals Inc.盘中异动 股价大跌6.17%
市场透视 · 05-27
Milestone Pharmaceuticals Inc.盘中异动 股价大跌6.17%
Milestone Pharmaceuticals Inc.2025财年第一财季实现净利润-20.76百万美元,同比减少100.58%
市场透视 · 05-22
Milestone Pharmaceuticals Inc.2025财年第一财季实现净利润-20.76百万美元,同比减少100.58%
Milestone Pharmaceuticals Inc.盘中异动 大幅拉升5.04%
市场透视 · 05-20
Milestone Pharmaceuticals Inc.盘中异动 大幅拉升5.04%
Milestone Pharmaceuticals Inc.盘中异动 早盘快速上涨5.33%报1.29美元
市场透视 · 05-19
Milestone Pharmaceuticals Inc.盘中异动 早盘快速上涨5.33%报1.29美元
Milestone Pharmaceuticals Inc.盘中异动 快速拉升5.22%
市场透视 · 05-16
Milestone Pharmaceuticals Inc.盘中异动 快速拉升5.22%
Milestone Pharmaceuticals Inc.盘中异动 急速下挫6.72%报1.11美元
市场透视 · 05-14
Milestone Pharmaceuticals Inc.盘中异动 急速下挫6.72%报1.11美元
Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.04%报1.17美元
市场透视 · 05-12
Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.04%报1.17美元
Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.00%报1.14美元
市场透视 · 05-09
Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.00%报1.14美元
Milestone Pharmaceuticals Inc.盘中异动 早盘快速下跌5.19%报1.28美元
市场透视 · 04-29
Milestone Pharmaceuticals Inc.盘中异动 早盘快速下跌5.19%报1.28美元
Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌5.17%报1.10美元
市场透视 · 04-24
Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌5.17%报1.10美元
Milestone Pharmaceuticals Inc.盘中异动 早盘快速上涨5.19%
市场透视 · 04-23
Milestone Pharmaceuticals Inc.盘中异动 早盘快速上涨5.19%
Milestone Pharmaceuticals Inc.盘中异动 快速拉升5.45%报1.07美元
市场透视 · 04-22
Milestone Pharmaceuticals Inc.盘中异动 快速拉升5.45%报1.07美元
Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.32%
市场透视 · 04-16
Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.32%
加载更多
公司概况
公司名称:
Milestone Pharmaceuticals Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Milestone Pharmaceuticals Inc.于2003年根据魁北克省法律注册成立。该公司是一家专注于心血管创新药物开发和商业化的生物制药公司。公司主导候选产品曲立帕米是一种新型强效钙通道阻滞剂,他们将其设计为一种快速起效的鼻腔喷雾剂,供患者自行给药。该公司正在开发用于治疗特定心律失常的曲立帕米,其主要适应症是治疗阵发性室上性心动过速,或PSVT,随后的适应症是治疗具有快速心室率的心房颤动,或AFIB-RVR。
发行价格:
--
{"stockData":{"symbol":"MIST","market":"US","secType":"STK","nameCN":"Milestone Pharmaceuticals Inc.","latestPrice":1.56,"timestamp":1752264000000,"preClose":2.56,"halted":0,"volume":21239226,"hourTrading":{"tag":"盘后","latestPrice":1.6093,"preClose":1.56,"latestTime":"19:59 EDT","volume":133336,"amount":212510.3734,"timestamp":1752278398235},"delay":0,"floatShares":50946200,"shares":53464273,"eps":-0.667393,"marketStatus":"休市中","change":-1,"latestTime":"07-11 16:00:00 EDT","open":1.74,"high":1.94,"low":1.46,"amount":34080442.924296595,"amplitude":0.1875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.667393,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1557374400000,"exchange":"NASDAQ","adjPreClose":2.56,"preHourTrading":{"tag":"盘前","latestPrice":1.74,"preClose":2.56,"latestTime":"09:29 EDT","volume":726345,"amount":1368310.065543,"timestamp":1752240597054},"postHourTrading":{"tag":"盘后","latestPrice":1.6093,"preClose":1.56,"latestTime":"19:59 EDT","volume":133336,"amount":212510.3734,"timestamp":1752278398235},"volumeRatio":16.64044317266908,"impliedVol":1.0563,"impliedVolPercentile":0.1},"requestUrl":"/m/hq/s/MIST","defaultTab":"news","newsList":[{"id":"2550673090","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550673090","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550673090?lang=zh_cn&edition=full","pubTime":"2025-07-11 03:28","pubTimestamp":1752175689,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日03时28分,Milestone Pharmaceuticals Inc.股票出现波动,股价快速拉升5.00%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.80%。其相关个股中,Pelthos Therapeutics Inc.、Q32 Bio Inc.、Lixte Biotechnology Holdings, Inc.涨幅较大,Cognition Therapeutics, Inc.、Q32 Bio Inc.、Calidi Biotherapeutics, Inc.较为活跃,换手率分别为388.30%、362.01%、354.38%,振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Q32 Bio Inc.、Pelthos Therapeutics Inc.,振幅分别为91.19%、90.07%、85.25%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071103280997a14e44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071103280997a14e44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2549580265","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘急速拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549580265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549580265?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:54","pubTimestamp":1751896484,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时54分,Milestone Pharmaceuticals Inc.股票出现波动,股价急速上涨5.15%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.60%。其相关个股中,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Pelthos Therapeutics Inc.涨幅较大,Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃,换手率分别为2772.05%、933.73%、754.37%,振幅较大的相关个股有Mustang Bio, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Osr Holdings Inc C/Wts 09/02/2028 ,振幅分别为244.54%、71.43%、52.80%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707215444a43bffa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707215444a43bffa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2546286002","title":"Milestone Pharmaceuticals Inc.盘中异动 快速上涨5.01%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546286002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546286002?lang=zh_cn&edition=full","pubTime":"2025-06-26 02:20","pubTimestamp":1750875645,"startTime":"0","endTime":"0","summary":"北京时间2025年06月26日02时20分,Milestone Pharmaceuticals Inc.股票出现异动,股价急速上涨5.01%。截至发稿,该股报1.88美元/股,成交量45.3203万股,换手率0.85%,振幅5.84%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.68%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626022045952b7cfa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626022045952b7cfa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2545289410","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘急速上涨5.33%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545289410","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545289410?lang=zh_cn&edition=full","pubTime":"2025-06-23 22:02","pubTimestamp":1750687327,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日22时02分,Milestone Pharmaceuticals Inc.股票出现异动,股价大幅上涨5.33%。截至发稿,该股报1.78美元/股,成交量15.9417万股,换手率0.30%,振幅5.61%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.42%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623220207a4b93423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623220207a4b93423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2541143075","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2541143075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541143075?lang=zh_cn&edition=full","pubTime":"2025-06-05 21:30","pubTimestamp":1749130227,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时30分,Milestone Pharmaceuticals Inc.股票出现异动,股价大幅上涨5.15%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.00%。其相关个股中,Scinai Immunotherapeutics Ltd、Phio Pharmaceuticals Corp.、Promis Neurosciences Inc.涨幅较大,Scinai Immunotherapeutics Ltd、Nucana Plc、Silo Pharma, Inc.较为活跃,换手率分别为902.50%、154.19%、136.61%,振幅较大的相关个股有Jupiter Neurosciences, Inc.、Relay Therapeutics, Inc.、Phathom Pharmaceuticals, Inc.,振幅分别为7.36%、5.02%、4.68%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213027a49b7eed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213027a49b7eed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2540795093","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘急速拉升6.17%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540795093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540795093?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:43","pubTimestamp":1748871837,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时43分,Milestone Pharmaceuticals Inc.股票出现波动,股价急速上涨6.17%。截至发稿,该股报1.72美元/股,成交量9.1632万股,换手率0.17%,振幅4.63%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602214358a6f726fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602214358a6f726fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2539278348","title":"Milestone Pharmaceuticals Inc.盘中异动 急速下挫5.03%报1.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539278348","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539278348?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:43","pubTimestamp":1748612630,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时43分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速下挫5.03%。截至发稿,该股报1.51美元/股,成交量5.5341万股,换手率0.10%,振幅3.77%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为3.53%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053021435095085049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025053021435095085049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2538492499","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538492499","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538492499?lang=zh_cn&edition=full","pubTime":"2025-05-28 03:02","pubTimestamp":1748372530,"startTime":"0","endTime":"0","summary":"北京时间2025年05月28日03时02分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速跳水6.17%。截至发稿,该股报1.45美元/股,成交量111.756万股,换手率2.09%,振幅7.79%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.97%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528030210aa2c9ac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528030210aa2c9ac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2537232499","title":"Milestone Pharmaceuticals Inc.2025财年第一财季实现净利润-20.76百万美元,同比减少100.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537232499","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537232499?lang=zh_cn&edition=full","pubTime":"2025-05-23 00:00","pubTimestamp":1747929623,"startTime":"0","endTime":"0","summary":"5月23日,Milestone Pharmaceuticals Inc.公布财报,公告显示公司2025财年第一财季净利润为-20.76百万美元,同比减少100.58%;其中营业收入为0.00美元,每股基本收益为-0.31美元。机构评级:截至2025年5月23日,当前有4家机构对Milestone Pharmaceuticals Inc.目标价做出预测,其中目标均价为6.00美元,其中最低目标价为1.00美元,最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000050a6e913f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523000050a6e913f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST"],"gpt_icon":0},{"id":"2537464294","title":"Milestone Pharmaceuticals Inc.盘中异动 大幅拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537464294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537464294?lang=zh_cn&edition=full","pubTime":"2025-05-21 00:48","pubTimestamp":1747759718,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日00时48分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速拉升5.04%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.19%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Eyenovia, Inc.涨幅较大,Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃,换手率分别为4475.38%、1571.92%、1105.38%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Psyence Biomedical Ltd C/Wts 25/01/2029、Neuraxis, Inc.,振幅分别为174.55%、100.62%、100.00%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521004838a485a881&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521004838a485a881&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2536687723","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘快速上涨5.33%报1.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536687723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536687723?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:38","pubTimestamp":1747661919,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时38分,Milestone Pharmaceuticals Inc.股票出现异动,股价急速上涨5.33%。截至发稿,该股报1.29美元/股,成交量9.5506万股,换手率0.18%,振幅2.46%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.68%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213840a4842539&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213840a4842539&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2536487349","title":"Milestone Pharmaceuticals Inc.盘中异动 快速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536487349","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536487349?lang=zh_cn&edition=full","pubTime":"2025-05-17 01:36","pubTimestamp":1747416964,"startTime":"0","endTime":"0","summary":"北京时间2025年05月17日01时36分,Milestone Pharmaceuticals Inc.股票出现波动,股价快速上涨5.22%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.54%。其相关个股中,Affimed N.V.、Inozyme Pharma, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大,Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃,换手率分别为5133.88%、3189.91%、1602.93%,振幅较大的相关个股有Affimed N.V.、Onconetix, Inc.、Vor Biopharma Inc.,振幅分别为466.98%、66.89%、66.82%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517013605a4812cea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517013605a4812cea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2535782050","title":"Milestone Pharmaceuticals Inc.盘中异动 急速下挫6.72%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535782050","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535782050?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:31","pubTimestamp":1747229470,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时31分,Milestone Pharmaceuticals Inc.股票出现异动,股价大幅下挫6.72%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.16%。其相关个股中,Septerna, Inc.、蓝鸟生物、Nucana Plc涨幅较大,Nucana Plc、Quoin Pharmaceuticals Ltd、Polyrizon Ltd.较为活跃,换手率分别为1806.65%、1161.60%、1010.36%,振幅较大的相关个股有Quoin Pharmaceuticals Ltd、Annovis Bio, Inc.、Skye Bioscience, Inc.,振幅分别为9.91%、8.18%、7.72%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213110a47e3dfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514213110a47e3dfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2534279054","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大涨5.04%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534279054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534279054?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:32","pubTimestamp":1747056727,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时32分,Milestone Pharmaceuticals Inc.股票出现波动,股价快速上涨5.04%。截至发稿,该股报1.17美元/股,成交量2.1832万股,换手率0.04%,振幅0.00%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213207a6dc4ff7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512213207a6dc4ff7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2534480496","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.00%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534480496","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534480496?lang=zh_cn&edition=full","pubTime":"2025-05-09 21:42","pubTimestamp":1746798159,"startTime":"0","endTime":"0","summary":"北京时间2025年05月09日21时42分,Milestone Pharmaceuticals Inc.股票出现异动,股价大幅跳水5.00%。截至发稿,该股报1.14美元/股,成交量25.3268万股,换手率0.47%,振幅6.67%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214239aa2c8903&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250509214239aa2c8903&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2531756197","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘快速下跌5.19%报1.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531756197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531756197?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:31","pubTimestamp":1745933495,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分,Milestone Pharmaceuticals Inc.股票出现异动,股价急速跳水5.19%。截至发稿,该股报1.28美元/股,成交量2.3135万股,换手率0.04%,振幅1.48%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为1.78%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921313594e79b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042921313594e79b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2529931531","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘股价大跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529931531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529931531?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:56","pubTimestamp":1745502980,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时56分,Milestone Pharmaceuticals Inc.股票出现波动,股价大幅跳水5.17%。截至发稿,该股报1.10美元/股,成交量22.4779万股,换手率0.42%,振幅6.40%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.20%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424215621a6c6b46b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424215621a6c6b46b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2529816666","title":"Milestone Pharmaceuticals Inc.盘中异动 早盘快速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529816666","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529816666?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415066,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分,Milestone Pharmaceuticals Inc.股票出现异动,股价快速上涨5.19%。截至发稿,该股报1.12美元/股,成交量4.371万股,换手率0.08%,振幅0.00%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.57%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321310794dfa6c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321310794dfa6c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0},{"id":"2529845825","title":"Milestone Pharmaceuticals Inc.盘中异动 快速拉升5.45%报1.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529845825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529845825?lang=zh_cn&edition=full","pubTime":"2025-04-22 21:38","pubTimestamp":1745329131,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日21时38分,Milestone Pharmaceuticals Inc.股票出现异动,股价大幅上涨5.45%。截至发稿,该股报1.07美元/股,成交量15.8179万股,换手率0.30%,振幅3.96%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体涨幅为0.95%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221385194de3469&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042221385194de3469&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MIST","BK4007"],"gpt_icon":0},{"id":"2527452512","title":"Milestone Pharmaceuticals Inc.盘中异动 股价大跌5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527452512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527452512?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:47","pubTimestamp":1744811220,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时47分,Milestone Pharmaceuticals Inc.股票出现波动,股价急速下挫5.32%。截至发稿,该股报0.790美元/股,成交量7.3693万股,换手率0.14%,振幅2.77%。Milestone Pharmaceuticals Inc.股票所在的生物技术行业中,整体跌幅为0.97%。Milestone Pharmaceuticals Inc.公司简介:Milestone Pharmaceuticals Inc是一家生物制药公司,致力于开发和商业化用于心血管药物治疗的etripamil。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214700973a0393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214700973a0393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MIST"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.milestonepharma.com","stockEarnings":[{"period":"1week","weight":-0.1959},{"period":"1month","weight":-0.093},{"period":"3month","weight":1.0226},{"period":"6month","weight":-0.25},{"period":"1year","weight":0.0331},{"period":"ytd","weight":-0.339}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Milestone Pharmaceuticals Inc.于2003年根据魁北克省法律注册成立。该公司是一家专注于心血管创新药物开发和商业化的生物制药公司。公司主导候选产品曲立帕米是一种新型强效钙通道阻滞剂,他们将其设计为一种快速起效的鼻腔喷雾剂,供患者自行给药。该公司正在开发用于治疗特定心律失常的曲立帕米,其主要适应症是治疗阵发性室上性心动过速,或PSVT,随后的适应症是治疗具有快速心室率的心房颤动,或AFIB-RVR。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.042562},{"month":2,"riseRate":0.166667,"avgChangeRate":-0.118335},{"month":3,"riseRate":0.5,"avgChangeRate":-0.166289},{"month":4,"riseRate":0.666667,"avgChangeRate":0.196115},{"month":5,"riseRate":0.666667,"avgChangeRate":0.024602},{"month":6,"riseRate":0.571429,"avgChangeRate":0.044863},{"month":7,"riseRate":0.714286,"avgChangeRate":0.167769},{"month":8,"riseRate":0.5,"avgChangeRate":0.054646},{"month":9,"riseRate":0.5,"avgChangeRate":-0.000002},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.145809},{"month":11,"riseRate":0.5,"avgChangeRate":0.111894},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.060182}],"exchange":"NASDAQ","name":"Milestone Pharmaceuticals Inc.","nameEN":"Milestone Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Milestone Pharmaceuticals Inc.,MIST,Milestone Pharmaceuticals Inc.股票,Milestone Pharmaceuticals Inc.股票老虎,Milestone Pharmaceuticals Inc.股票老虎国际,Milestone Pharmaceuticals Inc.行情,Milestone Pharmaceuticals Inc.股票行情,Milestone Pharmaceuticals Inc.股价,Milestone Pharmaceuticals Inc.股市,Milestone Pharmaceuticals Inc.股票价格,Milestone Pharmaceuticals Inc.股票交易,Milestone Pharmaceuticals Inc.股票购买,Milestone Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Milestone Pharmaceuticals Inc.(MIST)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Milestone Pharmaceuticals Inc.(MIST)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}